Eitan Amir
Clinical benefit of cancer drugs approved in Switzerland 2010-2019.
Adam R, Tibau A, Molto Valiente C, Seruga B, Ocana A, Amir E, Templeton A. Clinical benefit of cancer drugs approved in Switzerland 2010-2019. PloS one 2022; 17:e0268545.
10.06.2022Clinical benefit of cancer drugs approved in Switzerland 2010-2019.
10.06.2022PloS one 2022; 17:e0268545
Adam Roman, Tibau Ariadna, Molto Valiente Consolación, Seruga Bostjan, Ocana Alberto, Amir Eitan, Templeton Arnoud J
Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression.
Adam R, Diez-Gonzalez L, Ocana A, Seruga B, Amir E, Templeton A. Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression. Exp Mol Pathol 2017; 102:455-474.
12.05.2017Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression.
12.05.2017Exp Mol Pathol 2017; 102:455-474
Adam Roman, Diez-Gonzalez Laura, Ocana Alberto, Seruga Bostjan, Amir Eitan, Templeton Arnoud J
Circulating DNA and survival in solid tumors
Ocana A, Pandiella A, Andrés-Pretel F, Seruga B, Corrales-Sanchez V, Serrano-Heras G, Gascon-Escribano M, Vera-Badillo F, Templeton A, Garcia-Olmo D, Diez-Gonzalez L, Amir E. Circulating DNA and survival in solid tumors. Cancer Epidemiol Biomarkers Prev 2015
24.11.2015Circulating DNA and survival in solid tumors
24.11.2015Cancer Epidemiol Biomarkers Prev 2015
Ocana Alberto, Pandiella Atanasio, Andrés-Pretel Fernando, Seruga Bostjan, Corrales-Sanchez Verónica, Serrano-Heras Gemma, Gascon-Escribano Maria José, Vera-Badillo Francisco, Templeton Arnoud, Garcia-Olmo Dolores C, Diez-Gonzalez Laura, Amir Eitan
Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses
Ocana A, Pandiella A, Niraula S, Seruga B, Vera-Badillo F, Templeton A, Gascón-Escribano M, Srikanthan A, Corrales-Sanchez V, Diez-Gonzalez L, Ethier J, Amir E. Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses. Oncotarget 2015
04.10.2015Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses
04.10.2015Oncotarget 2015
Ocana Alberto, Pandiella Atanasio, Niraula Saroj, Seruga Bostjan, Vera-Badillo Francisco, Templeton Arnoud, Gascón-Escribano María J, Srikanthan Amirrtha, Corrales-Sanchez Verónica, Diez-Gonzalez Laura, Ethier Josee-Lyne, Amir Eitan
Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer
Vera-Badillo F, Tannock I, Bedard P, Goldstein R, Seruga B, Templeton A, Ocana A, Kuruzar G, Chang M, Amir E. Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer. J Clin Pathol 2015
15.06.2015Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer
15.06.2015J Clin Pathol 2015
Vera-Badillo Francisco E, Tannock Ian F, Bedard Philippe L, Goldstein Robyn, Seruga Bostjan, Templeton Arnoud, Ocana Alberto, Kuruzar Gordana, Chang Martin C, Amir Eitan
Influence of censoring on conclusions of trials for women with metastatic breast cancer
Templeton A, Ace O, Amir E, Vera-Badillo F, Ocana A, Pond G, Tannock I. Influence of censoring on conclusions of trials for women with metastatic breast cancer. Eur J Cancer 2015
26.02.2015Influence of censoring on conclusions of trials for women with metastatic breast cancer
26.02.2015Eur J Cancer 2015
Templeton Arnoud, Ace Olga, Amir Eitan, Vera-Badillo Francisco, Ocana Alberto, Pond Gregory R, Tannock Ian F
Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs
Tibau A, Barnadas A, Seruga B, Ocana A, Templeton A, Vera-Badillo F, Ethier J, Srikanthan A, Bedard P, Amir E. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol 2014; 33:100-6.
10.11.2014Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs
10.11.2014J Clin Oncol 2014; 33:100-6
Tibau Ariadna, Barnadas Agustí, Seruga Bostjan, Ocana Alberto, Templeton Arnoud, Vera-Badillo Francisco E, Ethier Josee-Lyne, Srikanthan Amirrtha, Bedard Philippe L, Amir Eitan
Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis
Templeton A, Diez-Gonzalez L, Ace O, Vera-Badillo F, Seruga B, Jordán J, Amir E, Pandiella A, Ocana A. Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis. Cancer Treat Rev 2014; 40:1048-55.
03.09.2014Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis
03.09.2014Cancer Treat Rev 2014; 40:1048-55
Templeton Arnoud, Diez-Gonzalez Laura, Ace Olga, Vera-Badillo Francisco, Seruga Bostjan, Jordán Joaquín, Amir Eitan, Pandiella Atanasio, Ocana Alberto
Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment
Vera-Badillo F, Ocana A, Templeton A, Tibau A, Amir E, Tannock I. Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment. J Clin Oncol 2014; 32:3197.
04.08.2014Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment
04.08.2014J Clin Oncol 2014; 32:3197
Vera-Badillo Francisco E, Ocana Alberto, Templeton Arnoud, Tibau Ariadna, Amir Eitan, Tannock Ian F
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio
Templeton A, Tannock I, de Bono J, Attard G, Vera-Badillo F, Leibowitz-Amit R, McNamara M, Omlin A, Pezaro C, Amir E. Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer 2014; 120:3346-52.
03.07.2014Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio
03.07.2014Cancer 2014; 120:3346-52
Templeton Arnoud, Tannock Ian F, de Bono Johann S, Attard Gerhardt, Vera-Badillo Francisco E, Leibowitz-Amit Raya, McNamara Mairead G, Omlin Aurelius, Pezaro Carmel, Amir Eitan
Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis
Vera-Badillo F, Napoleone M, Ocana A, Templeton A, Seruga B, Al-Mubarak M, AlHashem H, Tannock I, Amir E. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 2014; 146:235-44.
14.06.2014Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis
14.06.2014Breast Cancer Res Treat 2014; 146:235-44
Vera-Badillo Francisco E, Napoleone Marc, Ocana Alberto, Templeton Arnoud, Seruga Bostjan, Al-Mubarak Mustafa, AlHashem Hashem, Tannock Ian F, Amir Eitan
Systemic Therapy for Non-clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
Vera-Badillo F, Escudier B, Tannock I, Knox J, Aneja P, de Gouveia P, Ocana A, Duran I, Templeton A, Amir E. Systemic Therapy for Non-clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis. Eur Urol 2014
29.05.2014Systemic Therapy for Non-clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
29.05.2014Eur Urol 2014
Vera-Badillo Francisco E, Escudier Bernard, Tannock Ian F, Knox Jennifer J, Aneja Priya, de Gouveia Paulo, Ocana Alberto, Duran Ignacio, Templeton Arnoud, Amir Eitan
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
Templeton A, Tannock I, Tran B, Knox J, Sonpavde G, Leibowitz-Amit R, Ocana A, Aneja P, Vera-Badillo F, Seruga B, McNamara M, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106:dju124.
29.05.2014Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
29.05.2014J Natl Cancer Inst 2014; 106:dju124
Templeton Arnoud, Tannock Ian F, Tran Ben, Knox Jennifer J, Sonpavde Guru, Leibowitz-Amit Raya, Ocana Alberto, Aneja Priya, Vera-Badillo Francisco E, Seruga Bostjan, McNamara Mairead G, Amir Eitan
Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
Templeton A, Tannock I, Ocana A, Seruga B, Hermanns T, Vera-Badillo F, Al-Mubarak M, McNamara M, Ace O, Amir E. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014; 23:1204-12.
03.05.2014Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
03.05.2014Cancer Epidemiol Biomarkers Prev 2014; 23:1204-12
Templeton Arnoud, Tannock Ian F, Ocana Alberto, Seruga Bostjan, Hermanns Thomas, Vera-Badillo Francisco E, Al-Mubarak Mustafa, McNamara Mairead G, Ace Olga, Amir Eitan
Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis
Ocana A, Pandiella A, Seruga B, Cuenca-Lopez M, Diez-Gonzalez L, Corrales-Sanchez V, Templeton A, Al-Mubarak M, Vera-Badillo F, Amir E. Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis. PloS one 2014; 9:e95219.
28.04.2014Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis
28.04.2014PloS one 2014; 9:e95219
Ocana Alberto, Pandiella Atanasio, Seruga Bostjan, Cuenca-Lopez María D, Diez-Gonzalez Laura, Corrales-Sanchez Verónica, Templeton Arnoud, Al-Mubarak Mustafa, Vera-Badillo Francisco, Amir Eitan
Extended adjuvant tamoxifen for early breast cancer: a meta-analysis
Al-Mubarak M, Tibau A, Templeton A, Cescon D, Ocana A, Seruga B, Amir E. Extended adjuvant tamoxifen for early breast cancer: a meta-analysis. PloS one 2014; 9:e88238.
20.02.2014Extended adjuvant tamoxifen for early breast cancer: a meta-analysis
20.02.2014PloS one 2014; 9:e88238
Al-Mubarak Mustafa, Tibau Ariadna, Templeton Arnoud, Cescon David W, Ocana Alberto, Seruga Bostjan, Amir Eitan
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
Vera-Badillo F, Ocana A, Tannock I, Seruga B, Al-Mubarak M, Bedard P, Diaz-Padilla I, de Gouveia P, Templeton A, Amir E. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2013; 106:djt319.
22.11.2013Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
22.11.2013J Natl Cancer Inst 2013; 106:djt319
Vera-Badillo Francisco E, Ocana Alberto, Tannock Ian F, Seruga Bostjan, Al-Mubarak Mustafa, Bedard Philippe L, Diaz-Padilla Ivan, de Gouveia Paulo, Templeton Arnoud, Amir Eitan
Benefit and harms of new anti-cancer drugs
Vera-Badillo F, Al-Mubarak M, Templeton A, Amir E. Benefit and harms of new anti-cancer drugs. Curr Oncol Rep 2013; 15:270-5.
01.06.2013Benefit and harms of new anti-cancer drugs
01.06.2013Curr Oncol Rep 2013; 15:270-5
Vera-Badillo Francisco E, Al-Mubarak Mustafa, Templeton Arnoud, Amir Eitan